ArticleTrials2026

Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial.

Siri Opsahl Hetlevik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.